Kyle Quackenbush

Kyle Quackenbush specializes in class actions and other complex civil litigation, with a focus on antitrust. He has participated in all stages of litigation, including drafting pleadings, coordinating document discovery, taking depositions, filing dispositive motions, and attending trials. He is particularly interested in the interplay between antitrust and intellectual property law in the pharmaceutical industry as well as market concentration within the payor and provider networks in the United States’ healthcare industry.

Kyle currently volunteers with the Federal Pro Bono Project of the Bar Association of San Francisco. He represents a Plaintiff who alleges employees at Salinas Valley State Prison were deliberately indifferent to the Plaintiff’s serious medical needs, in violation of the Eighth Amendment.

During law school, Kyle was a Summer Honors Legal Intern at the Federal Trade Commission’s San Francisco office, and a Legal Extern at the Washington State Attorney General’s Office. While at the Federal Trade Commission, he co-authored “The Efficiencies Defenestration, Are Regulators Throwing Valid Healthcare Efficiencies Out The Window?” Competition, The Journal of the Antitrust and Unfair Competition Law Section of the California Lawyers Association, Winter 2017-18.

Kyle also volunteered with the Immigrant Families Advocacy Project and the Street Youth Legal Advocates of Washington, and helped immigrants apply for citizenship at Citizenship Workshops.

Kyle is a member of the American Bar Association and the Bar Association of San Francisco. He also actively participates in the Barristers Association of San Francisco, working with the pro bono committee to provide information and resources to lawyers who are in their first 10 years of practice.

• Altria-JUUL E-Cigarette Antitrust Litigation: The Firm is involved in e-cigarette antitrust lawsuits against Altria Group, Inc. and Juul Labs, Inc. (“JLI”) on behalf of individuals and businesses who purchased JUUL e-cigarette devices directly from JLI December 2018-present. The suits stem from an allegedly anticompetitive Altria/JLI agreement whereby Altria agreed to acquire an ownership interest in JLI in exchange for over $12 billion. Altria also allegedly agreed not to compete with JLI and to provide JLI valuable retail shelf space in the e-cigarette market. Through this agreement, JLI maintained its dominance in the e-cigarette market and earned monopoly profits;
• Facebook Content Moderators’ Safe Workplace Litigation: The Firm represents a prospective Plaintiff class against Facebook, Inc., alleging that Facebook failed to protect content moderators from developing post-traumatic stress disorder and other adverse effects resulting from constant viewing of offensive and extremely disturbing videos, images, and broadcasts posted to Facebook;
• Interior Molded Doors Litigation: The Firm is Interim Co-Lead Counsel for a proposed Indirect Purchaser Plaintiffs Class of individuals and companies who purchased interior molded doors from Defendants JELD-WEN, Inc. and Masonite Corporation. Plaintiffs allege that as a result of Defendants’ anticompetitive conduct, Plaintiffs and other potential Class members paid more for doors than they would have in a competitive environment; and
• Restasis Antitrust Litigation: The Firm is Interim Co-Lead Counsel representing the Self-Insured Schools of California in a class action lawsuit against Allergan, Inc. The suit alleges that Allergan participated in a scheme to delay generic competition to Allergan’s blockbuster Restasis drug and extended its monopoly in the Restasis market through a series of fraudulent and anticompetitive acts.